Frank G. Ondrey

Affiliations: 
Otolaryngology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Medicine and Surgery, Cell Biology, Oncology
Google:
"Frank Ondrey"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hall JA, Rusten M, Abughazaleh RD, et al. (2020) Effects of PPAR-γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies. Head & Neck
Rosas R, Buryska S, Silver R, et al. (2020) Retinoids Augment Thiazolidinedione PPARγ Activation in Oral Cancer Cells. Anticancer Research. 40: 3071-3080
Swenson DK, Wuertz BR, Ali MM, et al. (2020) Abstract 23: Precision medicine approaches to Fanconi anemia oral cancer personalized prevention and treatment Cancer Research. 80: 23-23
Ondrey FG. (2019) Pioglitazone, Nuclear Receptors, and Aerodigestive Prevention. Cancer Prevention Research (Philadelphia, Pa.). 12: 641-644
Galbraith AR, Seabloom DE, Wuertz BR, et al. (2019) Chemoprevention of lung carcinogenesis by dietary nicotinamide and inhaled budesonide. Cancer Prevention Research (Philadelphia, Pa.)
Miller WA, Wuertz BR, Ondrey FG. (2018) PPARγ-Mediated p21 Induction in Aerodigestive Preneoplastic Cell Lines. The Annals of Otology, Rhinology, and Laryngology. 3489418787833
Miller KA, Wuertz BR, Haynes AM, et al. (2018) Abstract LB-171: Potential chemopreventative treatments in Fanconi anemia related HNSCC Cancer Research. 78
Gutkind JS, Ondrey FG, Laronde D, et al. (2018) Abstract 4985: M4OC-Prevent: Clinical evaluation of metformin for oral cancer precision prevention Cancer Research. 78: 4985-4985
Wuertz BR, Darrah L, Wudel J, et al. (2017) Thiazolidinediones abrogate cervical cancer growth. Experimental Cell Research
Seabloom DE, Galbraith AR, Haynes AM, et al. (2017) Fixed-dose combinations of pioglitazone and metformin for lung cancer prevention. Cancer Prevention Research (Philadelphia, Pa.)
See more...